215 cardiovascular disease drugs in the pipeline, report finds

06/13/2013 | Drug Store News · PharmaTimes (U.K.)

A total of 215 drugs for heart disease and stroke are awaiting FDA approval or are in clinical trials, according to a report from the Pharmaceutical Research and Manufacturers of America. The lineup includes 30 for heart failure, 29 for lipid disorders, 19 for stroke and 17 for hypertension.

View Full Article in:

Drug Store News · PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ